...
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations
Shopping cart close
Scilex Holding Scilex Holding
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations

SEC FIlings

Home » Archive by Category "SEC FIlings" (Page 3)
14 Mar
SEC FIlings

Post-Effective amendments for registration statement

  • March 14, 2023
  • Posted by Ulisses

Read more

13 Mar
SEC FIlings

Post-Effective amendments for registration statement

  • March 13, 2023
  • Posted by Ulisses

Read more

13 Mar
SEC FIlings

Post-Effective amendments for registration statement

  • March 13, 2023
  • Posted by Ulisses

Read more

13 Mar
SEC FIlings

Annual Report to Security Holders

  • March 13, 2023
  • Posted by Ulisses

Read more

08 Mar
SEC FIlings

Other definitive proxy statements

  • March 8, 2023
  • Posted by Ulisses

Read more

07 Mar
SEC FIlings

Annual report for year ending December 31, 2022

  • March 7, 2023
  • Posted by Ulisses

Read more

03 Mar
SEC FIlings

General statement of acquisition of beneficial ownership

  • March 3, 2023
  • Posted by Ulisses

Read more

01 Mar
SEC FIlings

Current report

  • March 1, 2023
  • Posted by Jitendra

Read more

15 Feb
SEC FIlings

Prospectus [Rule 424(b)(3)]

  • February 15, 2023
  • Posted by Jitendra

Read more

15 Feb
SEC FIlings

Prospectus [Rule 424(b)(3)]

  • February 15, 2023
  • Posted by Jitendra

Read more

‹12345›»
Close
Recent Posts
  • scilex-no-pic
    Henry Ji, PhD
    August 21, 2025 No Comments
  • scilex-no-pic
    Stephen Ma
    August 21, 2025 No Comments
  • scilex-no-pic
    Jaisim Shah
    August 21, 2025 No Comments
  • scilex-no-pic
    Dorman Followwill 
    August 21, 2025 No Comments
  • Alexander Wu, PhD
    August 21, 2025 No Comments
scilex-holding-logo-white

Terms of Use  Privacy Policy  Contact

  • Follow us on Facebook
  • Follow us on LinkedIn
  • Contact us by email

©2025 Scilex Holding All Rights Reserved
Scilex Holding Company is the owner of Scilex Pharmaceuticals and Semnur Pharmaceuticals

Scroll To Top Sidebar
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept More info